Table 1

Characteristics of patients with hyperplastic polyposis syndrome (HPS) from multiple centres in The Netherlands, divided per centre

All centres (n=77)Centre 1 (n=43)Centre 2 (n=8)Centre 3 (n=7)Centre 4 (n=6)Centre 5 (n=5)Centre 6 (n=5)Centre 7 (n=3)
Median age at diagnosis (range)56 (40–74)55 (40–74)51 (42–69)56 (46–65)58 (56–67)51 (43–72)52 (45–61)57 (48–69)
Mean follow-up time in years (range)5.6 (0.5–26.6)4.4 (1.3–9.3)10.6 (2.9–26.4)6.4 (1.1–12.3)2.6 (1.2–5.1)4.3 (3.0–5.7)2.2 (1.5–4.1)4.4 (1.3–9.3)
Mean follow-up time after HPS diagnosis in years (range)4.0 (0.4–21.0)3.2 (1.3–6.1)8.1 (1.1–20.8)5.8 (1.1–11.7)2.1 (1.2–4.4)3.3 (1.9–4.7)2.2 (1.5–4.1)3.2 (1.3–6.1)
Median interval endoscopies in months (range)11 (1–96)9 (1–96)23 (5–26)7 (3–63)6 (1–17)8 (1–24)11 (3–53)13 (10–25)
Median number of HPs in patients (range)15 (2–53)14 (2–53)29 (11–73)25 (6–45)10 (6–27)12 (2–22)21 (9–41)16 (5–18)
Median number of proximal HPs in patients (range)8 (1–45)7 (1–30)29 (5–45)10 (2–21)7 (2–12)6 (2–12)10 (4–30)5 (5–13)
Number of patients with an HP > 10 mm47 (61%)25 (58%)5 (63%)5 (71%)3 (50%)4 (80%)4 (80%)1 (33%)
Patients with >1 SA40 (52%)32 (74%)1 (13%)2 (29%)1 (17%)3 (60%)01 (33%)
Median number of SAs in patients (range)1 (0–24)5 (0–24)0(0–6)0(0–8)0(0–1)1 (0–20)00 (0–1)
Patients with >1 adenoma53 (69%)31 (72%)6 (75%)6 (86%)3 (50%)4 (80%)3 (60%)0 (0–1)
Median number of adenomas in patients (range)2 (0–26)2 (0–26)2 (0–16)6 (0–14)1 (0–9)2 (0–3)1 (0–5)0 (0–7)
Patients with CRC27 (35%)15 (35%)6 (75%)3 (43%)1 (17%)002 (67%)
 At initial endoscopy22 (28.5%)11 (73%)6 (100%)2 (67%)1 (100%)002 (100%)
 Interval CRC5 (6.5%)4 (27%)01 (33%)0000
Total polyps19841124295216879311750
Number of HPs1407 (72%)705 (63%)258 (87%)161 (74%)74 (85%)61 (67%)109 (93%)39 (78%)
Number of SAs302 (15%)259 (23%)6 (2%)9 (4%)1 (1%)23 (25%)04 (8%)
Number of MPs2 (0.1%)2 (0.2%)000000
Number of adenomas273 (14%)160 (14%)31 (11%)46 (22%)12 (14%)9 (8%)8 (7%)7 (14%)
  • CRC, colorectal cancer; HPs, hyperplastic polyps; SAs, serrated adenomas.